Tokyo Metropolitan Government's Startup Support Program specializing in Drug design and medical startups

In cooperation with private sectors and external stakeholders with expertise in supporting startups in the drug design and medical fields, Tokyo Metropolitan Government will widely utilize their knowledge and resources to overcome issues such as fund raising, business strategy, and R&D, while aiming to strengthen, promote, and make the startup ecosystem in this field self-driven.

Scheme

Promoters:
Private companies that work with TMG to strengthen, promote, and self-organize the startup ecosystem in the drug design and medical fields.
Startup Supporters:
VC/financial institutions, universities, research institutions, large companies, incubators/accelerators, and other professionals with expertise in the drug design and medical fields.
Community:
A group or state in which drug design /medical startups and startup supporters are closely connected to each other as the core of the ecosystem.

Open for application of Promoters

In this project, the private sectors will be selected through open offering as the Promoters who will cooperate with Tokyo Metropolitan Government to strengthen, promote and make the startup ecosystem self-driven in the drug design and medical fields.
In cooperation with private sectors with expertise in building an ecosystem and Tokyo Metropolitan Government, the Promoter will provide multiple supports in business, fund raising and networking to startups and research teams in the drug design and medical fields for 3years. This project aims to make the startup ecosystem in the drug design and medical fields in Tokyo.

Contents of Support

Support by Promoters (planned)

In this project, Tokyo Metropolitan Government will conclude an agreement with a promoter who will be responsible for project management, strengthening, promoting, and self-starting the startup ecosystem in the drug design and medical fields, and providing support to startups in the fields.
drug design and medical startups will receive mentoring, networking, and other support from the promoter and other support providers invited by the promoter. Through regular progress sharing and mentoring, the drug design and medical startups will be able to receive advice and other support that will contribute to their business growth.

Payment of Agreement

Tokyo Metropolitan Government will cover the promoter a performance-based fee for the results of the efforts made by the promoter in cooperation. The KPI Evaluation Committee will evaluate the achievement of the KPIs set by the promoters and the results of the project as a whole, and the amount of the agreement payment will alternate in conjunction with the evaluation. The maximum amount of the agreement fee is 50 million yen for the first year and 70 million yen (tentative) for the following second and third years.

Past Initiatives

Please see below for Blockbuster TOKYO's initiatives in previous years.

For initiatives from previous years, please click here.(Only Japanese)

In this project, Tokyo Metropolitan Government will call for proposals from businesses to support startups in scaling up, discovering seeds, promoting investment, securing resources, and enhancing the support environment for open innovation, etc.

Requirement of the promoter

The following are the requirements for recruiting and selecting a promoter for this project.

The promoter must have a clear vision, strategy, and implementation plan to strengthen and promote the startup ecosystem in the drug design and medical fields, and to make it self-driven.
The applicant should have an understanding of the issues involved in the establishment and commercialization of drug design and medical startups, as well as the ability to design and implement an appropriate support scheme for the formation of an ecosystem.
The applicant should have a network of startup supporters both in Japan and abroad who can collaborate with the startups in the drug design and medical fields to solve their problems, and have the ability to attract them to the project.

Please refer to the application guideline for the other detailed promoter profile.

Role of the Promoters

Tokyo Metropolitan Government recognizes an ecosystem as a state in which a community becomes the core, the circle among startups and startup supporters will expand, the growth of startups will be promoted, and resources will be circulated. In this project, Tokyo Metropolitan Government expects that the promoters will form and activate the community that will be the core of the ecosystem, and eventually develop it into an ecosystem that will attract attention both domestic and international startup stakeholders.

Application Requirements

The following requirements will be considered for the application.
It is possible for multiple businesses to form a joint venture and apply, but in that case, a representative business entity should be determined and the representative business entity should submit the application. (In such cases, the agreement fee will be paid to the representative business entity.)

①

For-profit private sectors such as a joint stock company, partnership company (general partnership company, limited partnership company, limited liability company), and professional business(audit firm, or legal firm).

②

NPO, General Incorporated Association, General Incorporated Foundation

③

And other business entities that are acknowledged by TMG

Schedule

From Friday, November 4, 2022 to Noon Monday, December 5, 2022

Selection Process

The screening will be conducted in two stages: document review and presentation review by a panel of experts. The presentation review will be held in mid-December (tentative) for applicants who have passed the document review only. Details will be provided separately to applicants.

First round of screening (written documents): Early December
Second round of screening (presentation): Mid-December (tentative)
Notification of results: late December (tentative).

Pre-entry

Those who intend to apply should contact the Secretariat by e-mail.
Please note that the purpose of the pre-entry is to confirm the intent of the business to apply in advance, and does not preclude a business from declining to apply after pre-entry or applying without pre-entry.

For applying, please download the application form below, fill in the required information, and send the electronic data in the format specified in the application form to the secretariat. If the original documents are only in paper form, please scan them and send them as PDF files.

Application Guidelines, etc.
application form

Where to submit documents

Please read the application guidelines, fill in the required information, and send the electronic data of the specified application documents to the secretariat by e-mail.
To: Deloitte Touche Tohmatsu LLC (Attn: Hamada, Ishitsuka, Takada)
Mail:pj_bbt@tohmatsu.co.jp

Screening Process

The screening process are in two stages: ①document review and presentation review and ②the presentation review by a panel of experts that will be held in mid-December (tentative) for applicants who have passed the document review. Details will be sent to applicants.

Applications and inquiries for this project should be directed to the following office of secretariat.
(Not be able to respond to any inquiries regarding the screening process or results of the screening.)

Tokyo Metropolitan Government, drug design and Medical Startup Support Project
Phone: +81-3-6213-1251
Mail: pj_bbt@tohmatsu.co.jp

Team Tokyo Innovation for All the STARTUPs

Site Policy

Deloitte Touche Tohmatsu LLC (hereafter, Deloitte) recognizes the importance of protecting the personal information, such as program participants, acquired through business activities that include operating theTokyo Metropolitan Government's Startup Support Program specializing in Drug design and medical startups(hereafter, program) which has been commissioned by the Tokyo Metropolitan Government (hereafter , TMG ), and handles such personal information based on the following policy.

1. Acquisition of Personal Information
Deloitte will acquire Personal Information in a proper manner and refrain from acquiring Personal Information by improper means.

2. Compliance with laws and regulations, and others.
Deloitte will comply with the Act on the Protection of Personal Information, guidelines issued by relevant government agencies, and other laws and regulations pertaining to the appropriate handling of personal information.

3. Utilization of Personal Information

(1)Deloitte will only utilize acquired Personal Information within the scope of the purpose of utilization. When utilizing acquired Personal Information outside the scope of the purpose of utilization, consent from the individual will be sought in advance.

(2)When acquiring Personal Information, Deloitte will clearly state the purpose of utilization in advance, and will seek consent from the individual when changing the purpose of utilization.

(3)When implementing the Operation, Deloitte may contract out the handling of Personal Information to a third party. In that case, Personal Information will be appropriately managed with appropriate actions including concluding a contract with the third party regarding the handling of Personal Information, and supervising the handling of Personal Information at the third party.

4. Sharing Personal Information with a third party
Excluding instances stipulated by law and instances of sharing Personal Information with the government of Tokyo, the commissioner of the Operation, when Deloitte shares Personal Information with a third party, consent from the individual will be sought in advance. Personal Information will not be shared with a third party without obtaining consent from the individual.

5. Safety management system for Personal Information

(1)To prevent the loss, alteration, leakage, or other deteriorate of Personal Information, Deloitte appropriately implements safety management for handling Personal Information that includes information security and strives.

(2)Deloitte will clarify the person in charge to carry out appropriate management of Personal Information.

(3)Deloitte regularly reassesses the efforts and management system for protecting Personal Information to strive for continuous improvement.

(4)Deloitte conducts training on the protection and appropriate management methods or other actions regarding Personal Information for company employees/staff, and other workers who handle Personal Information in order to thoroughly implement appropriate handling of Personal Information in the Operation.

6. Disclosure, revision, suspension of utilization, etc.
When an individual seeks disclosure, revision, suspension of use and other suspicious actions of their own Personal Information based on the Act on the Protection of Personal Information, Deloitte will appropriately respond according to laws and regulations.

7. Inquiries regarding Personal Information
Please utilize the following contact information to make inquiries on handling of Personal Information.

Contact information regarding Personal Information
Deloitte Touche Tohmatsu LLC Trustee: Deloitte Touche Tohmatsu LLC
Mail:pj_bbt@tohmatsu.co.jp

Inquiry

Inquiries for this project should be directed to the following office of secretariat.

Tokyo Metropolitan Government, Drug design and Medical Startup Support Project

Trustee: Deloitte Touche Tohmatsu LLC (Attn: Hamada, Ishitsuka, Takada)
Mail:pj_bbt@tohmatsu.co.jp

In principle, the copyrights to the text, images, and other information posted on this site belong to the Tokyo Metropolitan Government. However, the copyrights to some images and other materials shall be owned by the original authors. No reproduction or diversion without permission, except as permitted under the Copyright Law.

About Technology

System Requirements

The following browsers are recommended to utilize this website more satisfactorily.

・Google Chrome latest version

・Microsoft Internet Explorer 11

・Mozilla Firefox latest version

・Safari latest version

・Microsoft Edge latest version

Technology Used

System Requirements

Cookie
This web site uses cookies for such purposes as understanding usage conditions and obtaining information to improve the site. Cookies are functions that store information about the user's visit to this site in the user's computer. The information collected through cookies does not contain any information that can identify individual users. Users shall be allowed to reject the receipt of cookies by setting your browser. For more details on the way to configure your browser settings, please contact the help function of your browser or the manufacturer of your software.

JavaScript
This website uses JavaScript for some of the contents to provide a better user experience. Please note that if JavaScript is not turned on (enabled) in your browser settings, some of the contents may not be displayed or operated correctly.

SSL(TLS)
This website uses SSL encrypted communication to improve the level of security. When users utlizes a web browser that supports security features, personal information is automatically encrypted before being sent and received. In some cases, such pages may not be available due to firewalls or other settings.

SNS
For social networking services such as Twitter, Facebook, YouTube, or other services, please refer to the terms of use of each site.

PDF
To view files in PDF format, users should download Adobe Acrobat Reader from Adobe Systems, Inc. If users do not own the AdobeAcrobat Reader installed, or if the contents of the website do not display properly, please download the latest version.

Excel and Word
This site will provide some attachments in Microsoft Excel and Word formats. Microsoft Excel and Word shall be downloaded required to view the subject attachments.

Legal Matters

Disclaimer

Deloitte provides no guarantee whatsoever for the integrity, accuracy, utility, reliability, or other responsibilities of the contents appearing on this website, and may alter, remove, delete the contents appearing on this website without any prior notification. Deloitte bears no responsibility whatsoever to damage that arises due to the contents on this website, or utilizing websites linked to from this website. Please remind that viewing this web site is on users' responsibilities.

Prohibited matters

The use of this website prohibits the following activities associated with the use of this Website.

・Activities that shall obstruct and hinder the operations of this Website.

・Activities that shall cause or be likely to cause troubles, disadvantages or harm to privacy of other users, third parties or Tokyo Metropolitan Government.

・Activities that shall be offensive or potentially offensive to public order and morals.

・Activities that shall breach laws, regulations or ordinances.

・Other activities that the TMG will deem as inappropriate.

Changes to the Website Policy

This website policy is subject to change without prior notice.

Applicable law and the court with jurisdiction

The utilization of this website, or the interpretation and application of the website’s policy will refer to the laws of Japan, unless otherwise indicated. In addition, Tokyo District Court will be the court of first instance with exclusive jurisdiction for any and all conflict related to the utilization of this website.